Serotonin and drug-induced therapeutic responses in major depression, obsessive-compulsive and panic disorders.
about
Impact of substance P receptor antagonism on the serotonin and norepinephrine systems: relevance to the antidepressant/anxiolytic responseThe noradrenergic paradox: implications in the management of depression and anxietyCurrent status of functional imaging in eating disordersSpadin, a sortilin-derived peptide, targeting rodent TREK-1 channels: a new concept in the antidepressant drug design.Cell type-dependent recruitment of trichostatin A-sensitive repression of the human 5-HT1A receptor gene5-HT1A receptors, gene repression, and depression: guilt by associationSelective serotonin reuptake inhibitors potentiate the rapid antidepressant-like effects of serotonin4 receptor agonists in the ratAltered serotonin and dopamine metabolism in the CNS of serotonin 5-HT(1A) or 5-HT(1B) receptor knockout mice5-hydroxytryptamine 2C receptors in the dorsal striatum mediate stress-induced interference with negatively reinforced instrumental escape behavior.Pharmacological blockade of 5-HT7 receptors as a putative fast acting antidepressant strategyVagus nerve stimulation (VNS) for depression: what do we know now and what should be done next?A functional Tph2 C1473G polymorphism causes an anxiety phenotype via compensatory changes in the serotonergic system.Serotonergic signalling suppresses ataxin 3 aggregation and neurotoxicity in animal models of Machado-Joseph disease.Targeted exome sequencing for the identification of a protective variant against Internet gaming disorder at rs2229910 of neurotrophic tyrosine kinase receptor, type 3 (NTRK3): A pilot study.A comparative review of escitalopram, paroxetine, and sertraline: Are they all alike?Cellular profile of the dorsal raphe lateral wing sub-region: relationship to the lateral dorsal tegmental nucleusAcute 5-HT reuptake blockade potentiates human amygdala reactivity.Metabolic mapping of the effects of the antidepressant fluoxetine on the brains of congenitally helpless rats.Serotonin (5-HT) receptor 5A sequence variants affect human plasma triglyceride levelsPharmacotherapies in the management of obsessive-compulsive disorder.The rapid recovery of 5-HT cell firing induced by the antidepressant vortioxetine involves 5-HT(3) receptor antagonism.Amine neurochemistry and aggression in crayfish.Fluctuations in [¹¹C]SB207145 PET binding associated with change in threat-related amygdala reactivity in humans.The serotonin transporter gene polymorphism and the effect of baseline on amygdala response to emotional facesPlatelet serotonergic markers as endophenotypes for obsessive-compulsive disorder.Anti-Apoptotic Protein Bcl-xL Expression in the Midbrain Raphe Region Is Sensitive to Stress and Glucocorticoids.Transcriptional dys-regulation in anxiety and major depression: 5-HT1A gene promoter architecture as a therapeutic opportunity.Chronic SSRI treatment exacerbates serotonin deficiency in humanized Tph2 mutant mice.RNAi-mediated serotonin transporter suppression rapidly increases serotonergic neurotransmission and hippocampal neurogenesisActivation of 5-HT1A autoreceptors in the dorsal raphe nucleus reduces the behavioral consequences of social defeatNeurobiological factors linking personality traits and major depression.Chronic fluoxetine treatment changes S100B expression during postnatal rat brain development.In vivo quantification of serotonin transporters using [(11)C]DASB and positron emission tomography in humans: modeling considerations.Effects of HTR1A C(-1019)G on amygdala reactivity and trait anxiety.Antagonist but not agonist labeling of serotonin-1A receptors is decreased in major depressive disorder.The Effects of 5-HTR1A Polymorphism on Cingulum Connectivity in Patients with Panic Disorder.Fluorine-18 Radiolabeled PET Tracers for Imaging Monoamine Transporters: Dopamine, Serotonin, and Norepinephrine.Serotonin and dopamine: unifying affective, activational, and decision functions.Oestrogen: an overlooked mediator in the neuropsychopharmacology of treatment response?Serotonin: imaging findings in eating disorders.
P2860
Q24567550-C3E5CA80-D1E7-4E3B-B930-C7A6393B61FBQ26752868-39787D91-7241-4F55-BF15-01AB8BAB9F32Q26851996-C3058C0C-9520-4503-956B-91A7CD7F4530Q27324635-DF057BA6-B630-4A36-AD5B-FD8D3EC1A0B3Q28241899-9E475698-6C0C-441C-A2D7-61FC264B0A01Q28292310-0FCF8985-479F-491E-8D76-B358DEBBEB02Q28472928-1DC3A411-3F31-400D-B7FE-4696A8B512DFQ28586663-33997426-5BEC-4AA9-93EB-508E6566EB32Q30460367-BEA66557-53FC-44B8-A312-FA1DC7D3D35CQ30468153-D9090B85-D5FA-46A7-A97B-B876AD23645EQ30483287-A2A4C0F9-E2E0-4E68-AB28-A9AE490DA0A3Q30521113-48049AF3-24E7-4F10-B066-CDD37C5C1EDFQ30703360-5E31E74B-A29A-42C9-A87A-A6A1DB9BF830Q30843187-3A7AFA22-4595-4836-B437-FC3330B7AE8AQ33718185-E3E9EB0D-BB1F-442A-A55A-238E2C4C07F1Q33787092-ACF2B931-7733-4566-A9D0-205979187820Q33805388-0837F80A-F842-485A-911F-16BE475C7FA3Q33976508-C2629669-5564-462E-80C3-A36C22DF95DBQ34545215-071FF854-AA88-4178-8C15-D38F64FFA47EQ34547177-BAB3DFD0-DF0C-400B-9CAA-56C3BFA717B7Q34644369-2254A625-6550-403F-89A5-4F8E8FD26DE9Q35050013-06014578-DE12-429B-A220-0EF5220B9FF2Q35421231-484AC5B2-EE77-4123-90F2-C9569E254666Q35532160-AEFB1CC3-8013-41DC-ADFB-8B3B79ED315CQ35828514-11DEF1D0-7B85-42B2-B284-2569D30E468EQ35856895-E5901825-3796-4EE3-9351-412E4A234470Q35887986-DE372CBD-CA18-4B4B-886A-A2DF64E5A3A7Q36540891-F48E855F-D1E2-4183-81BD-FA943A8419DFQ36593806-0ED409D6-513A-4F9B-8BCB-D5BF216F7EBAQ36947237-62D70960-2038-41C7-A8C6-6950A4A90F5FQ37089315-7115074A-B111-420B-928F-18A54625E3ACQ37187661-FD2E2FE1-0E5C-401C-9653-39576E85EC33Q37199649-D3519F75-E668-47FF-B736-DCF318538B55Q37328993-03BF1D2E-5115-4BD2-BA82-94BF923F875DQ37367855-A4F18057-DFCA-4091-8D59-E886AD395000Q37516089-28553397-328E-4785-B23E-4CA3DAD21FAEQ37706110-BE071FC2-53C0-4274-BC77-63D1E57D09B9Q37782264-8228D76D-A993-47B7-9167-460FDE4712BDQ37791238-5C3ED059-8F53-46E8-9C5B-385B7A1CAF11Q37829680-1B477A80-19CB-4FAB-BF53-E5CCD276B0B5
P2860
Serotonin and drug-induced therapeutic responses in major depression, obsessive-compulsive and panic disorders.
description
1999 nî lūn-bûn
@nan
1999 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Serotonin and drug-induced the ...... ompulsive and panic disorders.
@ast
Serotonin and drug-induced the ...... ompulsive and panic disorders.
@en
type
label
Serotonin and drug-induced the ...... ompulsive and panic disorders.
@ast
Serotonin and drug-induced the ...... ompulsive and panic disorders.
@en
prefLabel
Serotonin and drug-induced the ...... ompulsive and panic disorders.
@ast
Serotonin and drug-induced the ...... ompulsive and panic disorders.
@en
P1476
Serotonin and drug-induced the ...... ompulsive and panic disorders.
@en
P2093
C de Montigny
P304
P356
10.1016/S0893-133X(99)00036-6
P407
P433
P577
1999-08-01T00:00:00Z
P6179
1043551284